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Abstract
Background: Virtually all low- and middle-income countries are undergoing an epidemiological transition whose
progression is more varied than experienced in high-income countries. Observed changes in mortality and disease
patterns reveal that the transition in most low- and middle-income countries is characterized by reversals, partial
changes and the simultaneous occurrence of different types of diseases of varying magnitude. Localized
characterization of this shifting burden, frequently lacking, is essential to guide decentralised health and social
systems on the effective targeting of limited resources. Based on a rigorous compilation of mortality data over two
decades, this paper provides a comprehensive assessment of the epidemiological transition in a rural South African
population.
Methods: We estimate overall and cause-specific hazards of death as functions of sex, age and time period from
mortality data from the Agincourt Health and socio-Demographic Surveillance System and conduct statistical tests
of changes and differentials to assess the progression of the epidemiological transition over the period 1993–2013.
Results: From the early 1990s until 2007 the population experienced a reversal in its epidemiological transition,
driven mostly by increased HIV/AIDS and TB related mortality. In recent years, the transition is following a positive
trajectory as a result of declining HIV/AIDS and TB related mortality. However, in most age groups the cause of
death distribution is yet to reach the levels it occupied in the early 1990s. The transition is also characterized by
persistent gender differences with more rapid positive progression in females than males.
Conclusions: This typical rural South African population is experiencing a protracted epidemiological transition. The
intersection and interaction of HIV/AIDS and antiretroviral treatment, non-communicable disease risk factors and
complex social and behavioral changes will impact on continued progress in reducing preventable mortality and
improving health across the life course. Integrated healthcare planning and program delivery is required to improve
access and adherence for HIV and non-communicable disease treatment. These findings from a local, rural setting
over an extended period contribute to the evidence needed to inform further refinement and advancement of
epidemiological transition theory.
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Background
Over time, mortality and disease patterns in human pop-
ulations transition from very high and fluctuating mor-
tality concentrated at younger ages and largely caused by
infectious diseases and nutritional deficiencies to rela-
tively stable low mortality concentrated at older ages
and largely caused by non-communicable diseases and
injuries – the ‘epidemiological transition’ [1]. High-
income countries experienced this transition in an or-
derly way along a unidirectional path during the first
half of the twentieth century [1]. The first phase of the
transition was characterized by high, fluctuating mortal-
ity dominated by epidemics of infectious diseases, fam-
ines and wars. Thereafter, mortality rates declined
progressively and degenerative diseases started to replace
infectious diseases as the major causes of morbidity and
death. Finally, in later stages of the transition, non-
communicable diseases such as cardiovascular diseases,
diabetes and cancers, and accidents became the main
causes of death, and mortality rates eventually stabilized
at relatively low levels [1–3]. In low- and middle-income
countries the epidemiological transition is still underway
and its progress is more varied compared to the experi-
ence of high-income countries. Observed changes in
mortality and disease patterns in most low- and middle-
income countries including those in sub-Saharan Africa
reveal transitions that are characterized by reversals, par-
tial changes and simultaneous occurrence of different
types of diseases [4–14].
For a long time in South Africa there was a steady de-
crease in the level of overall mortality. This trend was
reversed by the HIV/AIDS epidemic that dramatically
increased overall mortality from the mid-1990s to the
mid-2000s [6, 15–20]. In recent years, the availability
and use of antiretroviral treatment is reducing HIV/
AIDS-related mortality and life expectancy is rising
[18, 21, 22]. At the same time, modernization, eco-
nomic and social development over the past two de-
cades have resulted in the adoption of lifestyle
practices that expose South Africans to a variety of
risk factors for non-communicable diseases and injuries.
Hence, the cause of death profile of South Africans in-
creasingly includes non-communicable diseases, violence
and injuries [18, 21–30].
As the epidemiological transition continues to unfold
in South Africa, influenced by broader demographic,
socioeconomic, technological, political, and cultural
changes, there is ongoing need to quantify and
characterize it and its implications in different sub-
populations. This will reveal the history of the burden of
disease affecting different ethnic and social groups and
help identify and prioritize the interventions with poten-
tial for the greatest effect now and in the near future.
This need was highlighted by the Global Burden of
Disease study [31], which characterized the extent of re-
gional heterogeneity in the trajectories of the epidemio-
logical transition and called for greater availability and
understanding of local, national, and regional data. Char-
acterizing the shifting burden of mortality over time is
critical in areas without reliable data – particularly rural
settings where a greater evidence base can inform the
targeting of limited resources and identify rural-urban
differences and disparities.
Using mortality and cause of death data from the
Agincourt Health and Socio-Demographic Surveillance
System (HDSS), this article provides a comprehensive
assessment of the epidemiological transition in a rural
population in northeast South Africa over the period
1993–2013. This period spans major socio-political
changes, the start of the HIV/AIDS epidemic and avail-
ability of antiretroviral treatment. In the article we sig-
nificantly improve, update and extend measures of the
trends in mortality and cause of death profiles for the
Agincourt study population that have appeared earlier
[6, 18, 28]. Importantly, unlike the previous work we
operationalize the epidemiological transition using a
statistical framework that allows us to characterize its
progress relating overall mortality levels to changes in
the cause composition and conduct statistical tests of
changes and differentials. The longitudinal empirical evi-
dence from this study adds a further rural South African
dimension to the sparse literature on the current experi-
ence of the epidemiological transition across diverse
places and contexts in low- and middle-income settings.
Methods
Data
We use mortality and cause of death data collected from
1993 to 2013 as part of annual updates of vital events
conducted using the Agincourt HDSS in a population
occupying 27 villages in rural northeast South Africa
[32, 33]. The population is largely Shangaan (Tsonga)-
speaking. Former Mozambican refugees, who arrived in
the study area in the early to mid-1980s in the course
and aftermath of civil war, and their descendants, make
up about 30% of the population. The population has
been under epidemiological and demographic surveil-
lance since 1992 and vital events were updated at ap-
proximately 15- to 18-month intervals between 1993
and 1999, and annually since 1999.
Although the population has limited access to infra-
structure and public sector services, it has experienced
substantial socioeconomic changes over the years. As
documented in our earlier study [34], the proportion of
households that own assets associated with greater mod-
ern wealth has increased substantially over time. For ex-
ample, the proportion of households with dwellings
constructed with either brick or cement walls increased
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from 76% in 2001 to 98% in 2013; and the prevalence of
tiles as roof and floor materials of dwellings increased
respectively from 3% and 0.5% in 2001 to 15% and 14%
in 2013. In addition, the use of electricity for lighting
and cooking respectively increased from 69% and 4% of
households in 2001 to 96% and 50% of households in
2013. Other notable increases are in the proportion of
households owning stove, fridge, cellphone and car re-
spectively from 41%, 40%, 37% and 14% in 2001 to 85%,
86%, 98% and 20% in 2013.
For individuals identified as having died between the
annual surveillance update rounds, verbal autopsy (VA)
interviews were conducted with their caregivers to elicit
signs and symptoms of the illness or injury prior to their
death. The interviews were conducted one to 11 months
after death using a locally validated, local-language VA
instrument [33, 35].
Given the rigorous processes involved in the
collection, quality assurance and processing of HDSS
data [14, 36], the data from the Agincourt HDSS popula-
tion is one of the rare high-quality and methodologically
consistent longitudinal health and demographic dataset
for populations in resource-poor low- and middle-
income settings. The available mortality and cause of
death information by age and sex over an extended
period provides a unique opportunity for assessing how
populations in low- and middle-income settings, includ-
ing those in rural sub-Saharan Africa are currently ex-
periencing the epidemiological transition.
Assigning causes of death
We use the InterVA-4 probabilistic model (version 4.03)
to assign probable causes of death to every death with a
complete VA interview. For each death, the InterVA-4
model assigns up to three likely causes of death with as-
sociated likelihoods [37]. An indeterminate cause of
death is assigned when the VA information is inadequate
for the model to arrive at any cause of death. We opted
for InterVA-4 as opposed to physician-coded causes of
death because the InterVA-4 model assigns causes of
death in a standardized, automated manner that is much
quicker and more consistent than the former (particu-
larly for assessing changes over time and across settings).
Additionally, causes of death derived from InterVA-4
have been found to not substantially differ from those
generated by physician coding [38].
Statistical analysis
Trends in mortality and causes of death
Similar to some earlier studies [28, 39], we use discrete-
time event history analysis (DTEH) [40] to estimate
overall and cause-specific annual hazards of death as
functions of sex, age and time period. The annual hazard
of dying is the probability of dying during a one-year
interval starting on a particular date experienced by living
individuals, conditional on their state at the beginning of
the interval. An individual’s continuously evolving state is
described by the combination of values taken by both con-
stant and time-varying variables, for this study, sex, age
and time period.
One of the basic requirements of DTEH is the splitting
of each individual’s survival history into a set of discrete
person years [40]. We create a person-year file that con-
tains one record for each full year lived by each individ-
ual in the study population. For example, individuals
who died after one year of surveillance contribute one
person-year each while those who died after five years of
surveillance contribute five person-years. Only com-
pletely observed person-years are included in the data set
except when an individual dies before completing a
person-year time unit. Survival histories are truncated
for individuals who were alive at the beginning or end of
the study and for those who migrated in/out during the
study.
After constructing the person-year file we estimate the
annual hazards of dying using logistic regression models
[40–44]. Binary logistic regression models are used for
estimates of the risk of dying from all possible causes,
and multinomial logistic regression models are used to
obtain estimates of the risk of dying from causes in
broad cause of death categories. Using the estimated an-
nual hazards of death, we construct standard life tables
to derive life expectancies at birth and adult mortality
rates (the probability of dying between ages 15 and 60
for those who survive to age 15 if subjected to age-
specific mortality rates between those ages for the speci-
fied calendar year).
In order to contextualize the dynamics of the HIV epi-
demic and the availability of antiretroviral treatment
over time, the years of the study are divided into the fol-
lowing time periods: 1993–1997, 1998–2000, 2001–
2003, 2004–2007, 2008–2010 and 2011–2013. We also
categorize age into the following commonly used age
groups: 0–4, 5–14, 15–49, 50–64 and 65+. For the
cause-specific analyses, the most likely causes of death
generated by the InterVA-4 model except indeterminate
are categorized into four broad groups: (1) HIV/AIDS
and TB; (2) other communicable, maternal, perinatal,
and nutritional diseases (excluding HIV/AIDS and TB);
(3) non-communicable diseases; and (4) injuries, consist-
ent with the burden of disease classification system in
South Africa [23].
Changes in mortality and cause of death patterns
Following a common, standard approach to analyzing
changes in mortality and cause of death patterns, we div-
ide the most likely causes of death generated by the
InterVA-4 model into three broad cause groups that can
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be compared with existing publications: Group I
(communicable diseases, maternal, and perinatal con-
ditions and nutritional deficiencies), Group II (non-
communicable diseases), and Group III (accidents and
injuries) [45, 46]. The proportion of deaths attributed to
each cause group ranges from 0 to 1 and the set of pro-
portions for all of the cause groups sums to 1 after exclud-
ing indeterminate causes. We follow Salomon and Murray
[46] to relate the distribution of deaths among cause
groups to the overall level of mortality. We fit estimates of
age and cause-specific mortality fractions to a set of re-
gression equations of the following form
Y i1 ¼ β0 þ β1 ln Mið Þ þ εi1; and ð1Þ
Y i2 ¼ γ0 þ γ1 ln Mið Þ þ εi2: ð2Þ
where i indexes age; Yi1 and Yi2 are the log ratios of the
cause-specific fractions for Group II causes (P2) and
Group III causes (P3) relative to the cause-specific frac-
tion for Group I causes (P1): Y i1 ¼ ln P2P1
 
and Y i2 ¼ ln
P3
P1
 
; Mi is the all-cause mortality rate; β0 and γ0 are
constant terms and εi1 and εi2 are error terms. The coef-
ficients are estimated using seemingly unrelated regres-
sion models, separately for each sex and age group.
These models provide efficient means of jointly obtain-
ing estimates from a set of equations each with its own
error term that may be correlated with the error terms
of other equations. As in Salomon and Murray [46] we
compute predicted values for Y1 and Y2 for each
observation in the dataset. Those predicted values are
transformed into predicted proportions for each cause
group using the multivariate logistic transformation:
Pj ¼
exp Y j
 
1þPJ−1j¼1 exp Y j
 
where J = 3 and P3 is 1 − P1−P2.
Software
All analyses have been conducted using Stata version
14.1 (Stata Corp., College Station, USA).
Results
Over the period 1993–2013 the Agincourt HDSS re-
corded a total of 13,472 deaths in 1,604,085 person-years
of follow-up. Table 1 presents the person-years and
number of deaths grouped by time period and cause of
death categories. VA interviews were available for 92% of
the deaths. VA interviews were not conducted for the
other 8% of the deaths mainly due to failure to contact
suitable respondents. The InterVA-4 model assigned un-
determined cause of death to 6.2% of the deaths with VA
interviews.
Trends in mortality and cause of death
Table 2 presents summed annual probabilities of dying
from all causes for all age groups (per 1000), adult (ages
15–64) mortality rates (per 1000) and life expectancies at
Table 1 Person years and number of deaths by time period and cause of death categories, Agincourt, South Africa, 1993–2013
Sex Indicator 1993–1997 1998–2000 2001–2003 2004–2007 2008–2010 2011–2013
Female Person years 174,518 108,599 110,608 155,062 138,883 145,799
Number of Deaths
Total 773 677 1019 1651 1229 1096
HIV/AIDS & TB 200 226 505 825 476 286
Other Communicable 139 109 126 219 220 237
Non Communicable 248 203 238 391 424 452
Injuries 47 30 38 46 29 31
Indeterminate 52 46 44 93 48 41
VA interview not done 87 63 68 77 32 49
Male Person years 161,119 101,311 102,972 143,188 127,695 134,331
Number of Deaths
Total 900 708 1115 1833 1363 1108
HIV/AIDS & TB 243 256 480 755 528 300
Other Communicable 120 97 126 236 271 221
Non Communicable 234 158 230 420 337 352
Injuries 130 79 119 160 102 127
Indeterminate 44 20 40 74 49 46
VA interview not done 129 98 120 188 76 62
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Table 2 Trends in selected mortality indicators, Agincourt, South Africa, 1993–2013
Sex Year Annual probability of dying
(95% CI)
Adult mortality rate
(95% CI)
Life Expectancy at birth
(95% CI)
Female 1993 4.5 (3.8,5.2) 200.3 (159.7249.6) 73.7 (70.7,76.7)
1994 4.5 (3.8,5.2) 171.8 (134.2218.6) 73.2 (70.7,75.6)
1995 3.8 (3.2,4.5) 127.6 (93.6172.8) 74.8 (72.3,77.2)
1996 4.3 (3.6,5.0) 166.7 (127.6216.4) 74 (71.5,76.5)
1997 4.5 (3.9,5.2) 222.7 (180.1273.6) 74.6 (71.7,77.4)
1998 5.5 (4.8,6.3) 242 (202.2288.2) 70.6 (67.9,73.3)
1999 6.1 (5.3,6.9) 296.5 (254.2344.1) 69.3 (66.6,71.9)
2000 6.4 (5.6,7.2) 322.5 (275.3375.4) 67.7 (65.1,70.2)
2001 8.1 (7.3,9.1) 392 (347,440.6) 62.2 (59.8,64.5)
2002 8.7 (7.9,9.7) 469.2 (421.8519.3) 60.8 (58.3,63.2)
2003 9.6 (8.6,10.6) 463.5 (420.2509) 59.6 (57.2,62.1)
2004 9.4 (8.5,10.4) 503.3 (457.8550.8) 59.6 (57.2,62)
2005 11.3 (10.3,12.4) 536.4 (493.6580.5) 56.5 (54.3,58.7)
2006 9.9 (9.0,11.0) 476.2 (432,522.5) 59.7 (57.3,62)
2007 10.2 (9.3,11.2) 517.9 (474.6562.7) 58.6 (56.3,60.8)
2008 9.7 (8.8,10.6) 464.3 (422.8507.9) 60.4 (58.3,62.4)
2009 8.0 (7.3,8.9) 378.6 (338.3421.9) 65.3 (63.2,67.4)
2010 8.0 (7.2,8.8) 377.1 (337,420.3) 65.4 (63.3,67.5)
2011 7.9 (7.2,8.8) 359 (321.8399.2) 65.2 (63.1,67.3)
2012 7.2 (6.5,8) 317.2 (280.9357) 68.5 (66.4,70.5)
2013 6.7 (6,7.4) 294.9 (258.2335.5) 70.2 (68.2,72.3)
Male 1993 5.4 (4.7,6.3) 281.8 (229.5343.3) 67.8 (64.7,70.9)
1994 6 (5.2,6.9) 324.4 (267.8389.4) 63.6 (61.3,65.8)
1995 5 (4.3,5.8) 343.5 (284.6410.6) 67.2 (64.7,69.8)
1996 5.3 (4.6,6.2) 337.8 (282.7400.3) 66.9 (64,69.7)
1997 5.4 (4.7,6.3) 331 (277.1392.2) 65.7 (63.1,68.4)
1998 6.2 (5.4,7.1) 373 (317.6434.7) 64.4 (61.7,67)
1999 7.1 (6.3,8.1) 358.5 (306.6416.1) 62.3 (59.8,64.8)
2000 7 (6.2,8) 382 (328.9440.4) 62.3 (59.8,64.7)
2001 9.1 (8.1,10.1) 499.3 (446.5554.7) 57.2 (55,59.4)
2002 10.5 (9.5,11.7) 550.4 (499.3603) 53.6 (51.5,55.7)
2003 11.8 (10.7,12.9) 601.3 (552.8650.3) 51.7 (49.6,53.8)
2004 12 (10.9,13.2) 662.6 (615.9708.8) 51.3 (49.3,53.3)
2005 12.1 (11,13.3) 588.5 (541.2636.4) 52.3 (50.4,54.1)
2006 11.9 (10.9,13.1) 637.1 (591.5682.6) 52.1 (50.1,54)
2007 13.2 (12.1,14.4) 650 (607.3692.4) 49.9 (48.1,51.7)
2008 12.1 (11.1,13.2) 581.7 (539.4624.6) 52.1 (50.3,53.8)
2009 9.8 (9,10.8) 517.4 (473.2563.2) 56.6 (54.7,58.5)
2010 9.3 (8.5,10.3) 511.9 (466.4559.1) 57.6 (55.7,59.5)
2011 8.6 (7.8,9.5) 445.4 (398.7495.1) 59.8 (58,61.6)
2012 7.7 (6.9,8.5) 426.1 (380.2475) 61.5 (59.6,63.5)
2013 7.9 (7.2,8.8) 399.7 (355.4447.3) 61.3 (59.4,63.2)
Adult mortality rate is the probability of dying between ages 15 and 59
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birth. These estimates describe trends in all-cause mortal-
ity and are also shown in Fig. 1 panels (a), (b) and (c).
The annual probability of dying from all causes for all
ages was about 5.4 and 4.5 per 1000 person years in
1993 for males and females, respectively. Those started
to increase rapidly around 1997 for both males and fe-
males and reached a peak level around 2007 of 13.2 per
1000 person years for males and 11.3 per 1000 person
years around 2005 for females, before starting to decline
in more recent years. By 2013, the annual probability of
dying from all causes had reduced from peak levels to
7.9 per 1000 person years for males and 6.7 per 1000
person years for females. At the peak overall mortality
for both sexes had more than doubled to about 2.5 times
its starting value.
Adult mortality rates exhibit a similar pattern. From a
base of 281.8 and 200.3 per 1000 person years in 1993
for males and females, adult mortality rose to 650 per
1000 person years around 2007 for males and 536 per
1000 person years around 2005 for females, before start-
ing to decline. By 2013 adult mortality rates had reduced
from the peak levels to 399.7 per 1000 person years for
males and 294.9 per 1000 person years for females.
Trends in life expectancy at birth reflect trends in all-
age and adult mortality for both sexes. For females, life
expectancy at birth dropped from about 74 years in
1993 to about 57 years in 2005 (a loss of 17 years) and
returned to around 70 years by 2013. For males, life ex-
pectancy at birth dropped from about 68 years in 1993
to about 50 years in 2007 (a loss of 18 years) and in-
creased to around 61 years by 2013.
Figure 1 panel (d) shows the predicted summed annual
probability of dying per 1000 person years by year and
cause of death, estimated using a multinomial logistic re-
gression. The estimated probability of dying from each
cause is added to that of the other causes. Hence, the
cumulative area under each curve represents the prob-
ability of dying from the successively combined causes
in a given year. The annual probability of dying from
HIV/AIDS and TB increased dramatically after 2000,
reached a peak around 2004–2005 and has been de-
creasing since 2007. However, the level of HIV/AIDS
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Fig. 1 Trends in selected mortality and cause of death indicators, Agincourt, South Africa, 1993–2013. a All-Cause Mortality. b Adult Mortality. c
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and TB related mortality in the more recent time is still
higher than the level in 1993. Non-communicable dis-
eases have consistently been the next largest cause of
death and the probability of dying from them has in-
creased steadily over time. The probability of dying from
accidents and injuries has remained steady and low al-
though there is a major difference between males and fe-
males. Figure 2 shows summaries of the same trends in
the probabilities of dying from the different cause of
death categories with the years of follow-up divided into
six time periods.
Estimates of the risk of dying from different causes as
a function of sex, age and time period are presented in
Table S1 (see Additional file 1). Trends in the probabil-
ities of dying from each of the cause of death categories
by sex, age and time period, and the age-specific mar-
ginal linear predictions of dying from selected causes in
subsequent time periods relative to 1993–1997 obtained
from these estimates, are displayed in Figs. 3, 4 and 5.
The vertical scales for the probabilities of dying in
Fig. 3 are appreciably different between the different
age categories. Throughout time and for all ages,
males have higher probability of dying from all causes
compared to females. In all time periods, those aged
65+ have the highest probabilities of dying from all
causes followed respectively in descending order by
those aged 50–64, 0–4, 15–49 and 5–14.
In the 65+ age category non-communicable diseases
have been the leading cause of death for both males and
females and mortality associated with them has been ris-
ing steadily. Significant increases in non-communicable
disease mortality started to emerge in this age category
from 2004 to 2007 (RRR (95% CI): 1.51 (1.23, 1.84),
p < 0.001 for males and RRR (95% CI): 1.24 (1.02, 1.50),
p = 0.0271 for females in 2004–2007 relative to 1993–
1997). By 2011–2013, the risk of dying from non-
communicable diseases in this age category reached 1.69
(95% CI: 1.38, 2.06, p < 0.001) times as large as 1993–
1997 for males and 1.65 (95% CI: 1.38, 1.99, p < 0.001)
times as large as 1993–1997 for females.
In the 50–64-age category non-communicable diseases
have also been an important cause of death although the
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risk of dying from them over time relative to 1993–1997
has remained almost constant for both males and fe-
males. The risk of dying from non-communicable dis-
eases relative to 1993–1997 increased to statistically
significant levels in 2001–2003 (RRR (95% CI): 1.87
(1.37,2.56), p < 0.001) and remained constant thereafter in
males and was only statistically significant in 2001–2003
(RRR (95% CI): 1.58 (1.14,2.21), p = 0.007) in females.
HIV/AIDS and TB have also contributed significantly to
mortality in the 50–64 age category for both males and fe-
males. The probability of dying from HIV/AIDS and TB
in this age category steadily increased from the late 1990s
to the early 2000s and reached a peak in 2004–2007 (RRR
(95% CI): 3.36 (2.55, 4.43), p < 0.001 in 2004–2007 relative
to 1993–1997 for males; RRR (95% CI): 4.02 (3.00, 5.37),
p < 0.001 in 2004–2007 relative to 1993–1997 for fe-
males). Since then, HIV/AIDS and TB mortality has stead-
ily declined and has reached the baseline level for males
(RRR (95% CI): 1.33 (0.96,1.83), p = 0.083 in 2011–2013
relative to 1993–1997) and is closer to baseline level for
females (RRR (95% CI): 1.52 (1.08–2.13), p = 0.016 in
2011–2013 relative to 1993–1997).
In the 15–49 age category for both males and females
HIV/AIDS and TB have been the leading causes of
death. The probability of dying from HIV/AIDS and TB
in this age category increased dramatically from the late
1990s to the early 2000s, reached a peak in 2004–2007
(RRR (95% CI): 5.19 (4.25, 6.33), p < 0.001 in 2004–2007
relative to 1993–1997 for males; RRR (95% CI): 6.20
(5.12, 7.50), p < 0.001 in 2004–2007 relative to 1993–
1997 for females) and has steadily decreased since then.
Notwithstanding, HIV/AIDS and TB mortality in the
most recent time periods is still above what it was dur-
ing the early 1990s for both males (RRR (95% CI): 1.96
(1.56,2.46), p < 0.001 in 2011–2013 relative to 1993–1997)
and females (RRR (95% CI): 2.24 (1.80–2.78), p < 0.001 in
2011–2013 relative to 1993–1997). Both males and fe-
males in the 15–49 age category have also experienced
steady increases in the risk of dying from non-
communicable diseases over the years. By 2011–2013, the
risk of dying from non-communicable diseases in this age
category reached 2.89 (95% CI: 2.22, 3.76, p < 0.001) times
as large as 1993–1997 for males and 2.84 (95% CI: 2.17,
3.71, p < 0.001) times as large as 1993–1997 for females.
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Fig. 3 Trends in annual probability of dying by age, sex and cause of death, Agincourt, South Africa, 1993–2013
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In the 5–14 age category overall mortality increased
steadily from the late 1990s, reached a peak in 2004–
2007 and remained high until 2008–2010. Overall mor-
tality in this age group only started to decline in the
most recent time period following reductions in mortal-
ity from HIV/AIDS and TB. The risk of dying from
HIV/AIDS and TB in this age category reached peak
levels of 3.97 (95% CI: 2.07, 7.62, p < 0.001) times as
large as 1993–1997 for males and 4.04 (95% CI: 2.09,
7.79, p < 0.001) times as large as 1993–1997 for females
in 2008–2010 but dropped to the same level as 1993–
1997 in 2011–2013 (RRR (95% CI): 1.27 (0.56, 2.86),
p = 0.565 in 2011–2013 relative to 1993–1997 for males;
RRR (95% CI): 1.45 (0.64, 3.28), p = 0.371 in 2011–2013
relative to 1993–1997 for females).
In the 0–4 age group mortality has almost exclusively
been from HIV/AIDS and TB and other communicable
diseases. Trends in the pattern of overall mortality in
this age category have mirrored those of the HIV/AIDS
mortality pattern. For both males and females, HIV/
AIDS mortality in this age group increased steadily from
the mid 1990s, reached a peak in 2001–2003 (RRR (95%
CI): 3.16 (2.32, 4.30), p < 0.001 in 2001–2003 relative to
1993–1997 for males; RRR (95% CI): 3.66 (2.69, 5.00),
p < 0.001 in 2001–2003 relative to 1993–1997 for fe-
males) and has steadily decreased since then. In the
most recent time period the level of HIV/AIDS mortality
in this age category is equivalent to the level it was dur-
ing the 1993–1997 time period (RRR (95% CI): 0.68
(0.45, 1.04), p = 0.075 in 2011–2013 relative to 1993–
1997 for males; RRR (95% CI): 0.78 (0.51, 1.19),
p = 0.249 in 2011–2013 relative to 1993–1997 for
females).
Shifts in mortality and cause of death patterns
Table 3 and Figs. 6 and 7 present results from the ana-
lysis of the progression of the epidemiological transition
in the Agincourt study population for each sex, age cat-
egory. Table 3 shows the estimated coefficients from the
seemingly unrelated regression models. For most age
groups, the coefficients for all-cause mortality are statis-
tically significant. Figures 6 and 7 show, for males and
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Fig. 4 Age-specific marginal linear predictions of dying from selected causes of death in subsequent time periods relative to 1993–1997 for
males, Agincourt, South Africa, 1993–2013
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Fig. 5 Age-specific marginal linear predictions of dying from selected causes of death in subsequent time periods relative to 1993–1997 for
females, Agincourt, South Africa, 1993–2013
Table 3 Seemingly unrelated regression estimates of log ratios of cause fractions on all-cause mortality
Sex Coefficients for ln(P2/P1) Coefficients for ln(P3/P1)
Age ln(Mi) (95% CI) p-value Intercept (95% CI) p-value ln(Mi) (95% CI) p-value Intercept (95% CI) p-value
Female 0–4 −0.60 (−0.91,−0.28) < 0.001 −5.68 (−7.16,−4.21) < 0.001 −0.51 (−1.54,0.52) 0.329 −5.77 (−10.61,−0.93) 0.019
5–14 −0.20 (−1.97,1.58) 0.830 −3.05 (−15.71,9.62) 0.637 −1.89 (−3.78,0.01) 0.051 −15.09 (−28.62,−1.57) 0.029
15–49 −0.49 (−1.01,0.03) 0.063 −3.92 (−6.60,−1.24) 0.004 -1.24 (−1.66,−0.82) < 0.001 −9 (−11.17,−6.84) < 0.001
50–64 −0.61 (−0.97,−0.26) 0.001 −2.69 (−4.21,−1.16) 0.001 −1.15 (−1.84,−0.46) 0.001 −7.37 (−10.35,−4.39) < 0.001
65+ 1.70 (0.50,2.91) 0.006 6.54 (2.56,10.52) 0.001 −4.06 (−6.03,−2.09) < 0.001 −16.16 (−22.67,−9.66) < 0.001
Male 0–4 0.01 (−0.71,0.72) 0.983 −2.56 (−5.87,0.75) 0.129 −2.9 (−3.96,−1.83) < 0.001 −17.25 (−22.18,−12.32) < 0.001
5–14 −0.85 (−2.28,0.59) 0.249 −7.34 (−17.19,2.51) 0.144 −1.8 (−3.12,−0.47) 0.008 −12.98 (−22.06,−3.9) 0.005
15–49 −0.74 (−1.08,−0.39) < 0.001 −4.63 (−6.32,−2.94) < 0.001 −1.13 (−1.42,−0.84) < 0.001 −6.57 (−8.02,−5.12) < 0.001
50–64 −0.59 (−1.05,−0.13) 0.011 −2.50 (−4.20,−0.79) 0.004 −1.66 (−2.29,−1.03) < 0.001 −8.01 (−10.35,−5.67) < 0.001
65+ 0.46 (−0.36,1.28) 0.270 1.73 (−0.54,4.00) 0.136 −1.08 (−3.89,1.73) 0.451 −5.41 (−13.18,2.36) 0.172
Mi is the all-cause mortality rate for age category i; P1 is cause-specific fraction for Group I causes; P2 is cause-specific fraction for Group II causes and P3 is cause-
specific fraction for Group III causes.
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females respectively, the actual predicted proportions of
deaths attributed to each cause group using ternary dia-
grams. A ternary diagram is a graphical representation
of three variables which sum to a constant and depicts
ratios of three variables as positions in an equilateral tri-
angle. The diagrams reveal more detail on the progres-
sion of the transition for each sex and age category. The
points within each diagram are labeled with an abbrevi-
ation of the time period that omits the century, for ex-
ample 93–97 for 1993–1997. Each point simultaneously
represents the fraction of deaths attributed to the stand-
ard Group I (communicable diseases, maternal, and peri-
natal conditions and nutritional deficiencies), Group II
(non- communicable diseases), and Group III (accidents
and injuries) cause categories. The fraction of deaths at-
tributed to Group I causes is represented as the perpen-
dicular distance from the bottom of the triangle to the
top vertex; the fraction to Group II causes is the perpen-
dicular distance from the left side of the triangle to the
right vertex; and the fraction to Group III is the perpen-
dicular distance from the right side of the triangle to the
left vertex. For example, the point labeled 93–97 for
males aged 15–49 represents 47% of deaths from
Group I, 22% deaths from Group II and 31% deaths
from Group III. Diagrams for the 0–4 age group are
not included because there is little movement in this
age group. Thus the predictions show the direction
and magnitude of changes in cause of death patterns
as mortality changes.
From the perspective of classical understanding of epi-
demiological transition, the diagrams show reversals in
the progression of the transition in most age groups dur-
ing the periods of rising HIV/AIDS mortality. For most
age groups, the reversals peak during the 2004–2007
time period. The classic epidemiological transition is on
track (conforms to standard understanding) in recent
years following the widespread availability and uptake of
antiretroviral treatment. However, the progression of the
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Fig. 6 Shifts in mortality and cause of death patterns for males, Agincourt, South Africa, 1993–2013
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transition for most age categories has not yet quite re-
covered back to the stage it was in the early 1990s.
The diagrams also reveal the simultaneous impacts
and interactions of different cause groups as the epi-
demiological transition progresses in the positive direc-
tion, i.e. overall mortality falling. The time trajectory of
paths charting the progression of the transition varies by
sex. For the older age groups, the relative importance of
mortality from non-communicable diseases increases
first for females and then for males, although non-
communicable diseases become the dominant cause of
death for both sexes as all-cause mortality falls.
For young and middle-aged adults (15–49 years),
the relative contribution of mortality from injuries in-
creases more for males compared to females as the
transition progresses. For young and middle-aged
adult females, the relative contribution of mortality
from communicable causes is higher than for their
male counterparts.
Discussion
This paper has assessed the progress of the epidemio-
logical transition in a rural population in South Africa
undergoing profound health and social changes, using
mortality and cause of death data collected over two de-
cades through a robust health and socio-demographic
surveillance system. The findings improve, update and
extend published trends in mortality and cause of death
profiles [6, 18, 28] by including data from more recent
years that cover the widespread availability and uptake
of ART. Further, the analytical approach allows for the
progress of the epidemiological transition to be empiric-
ally assessed by relating overall mortality levels to
changes in the cause composition over time.
The results clearly exhibit elements of the “counter”
and “protracted” epidemiological transitions proposed by
Frenk [5] based on experiences in Mexico. The epi-
demiological transition in the Agincourt population
began a reversal in the early 1990s [6, 18] that continued
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Fig. 7 Shifts in mortality and cause of death patterns for females, Agincourt, South Africa, 1993–2013
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until around 2004–2007. This reversal was driven mostly
by increases in mortality attributable to HIV/AIDS and
TB. Only in recent years has the transition reversed
again and started to move in the positive direction, with
falling overall mortality and standard (as predicted by
the classic theory of the epidemiological transition)
changes to the cause of death distribution. This results
from the widespread availability and uptake of antiretro-
viral treatment (ART) that has successfully reduced the
number of deaths attributable to HIV/AIDS and TB.
Provision of ART started in three district hospitals sur-
rounding the study area between 2004 and 2005 [28, 47].
In 2007 a private community health centre specializing
in HIV care and treatment services and run in partner-
ship with the Department of Health, the Bhubezi
Community Health Centre, started operating in the
study area [47]. Provision of ART thereafter extended
to public primary care clinics in the study area be-
tween 2008 and 2009 and has become widespread
since 2010. However, despite improvements in recent
years and overall mortality in children under the age
of five years reaching the levels of 20 years before,
largely due to the success of prevention of mother-to-
child transmission (PMTCT) programmes [48], in
most age groups indicators of the epidemiological
transition have yet to reach the levels they occupied
in the early 1990s. Thus the epidemiological transi-
tion is still evolving, having been significantly delayed
by the HIV/AIDS epidemic. The progress of the tran-
sition has also been characterized by persistent gender
differences with faster positive progression in females
than males. Similar to other southern African settings,
this may be because rates of HIV testing and linkage
to and retention in care are higher in females than in
males [49–52].
We acknowledge several limitations to this study. First,
since updates of vital events in the Agincourt HDSS
occur once a year there is a possibility that some still
births, neonatal and infant deaths may not be recorded
particularly when births and deaths occur between con-
secutive household visits [32]. However, this bias is min-
imal in recent years because since 2000 names of the
most recent child born to each woman appear on the
pre-populated household roster and since 2006 there is
careful probing for pregnancies and births since the last
recorded child by asking about pregnancy status of every
woman of childbearing [32]. Second, we used data from
one defined geographic region in rural South Africa. As
such, the applicability of our findings elsewhere may not
be easy to establish. However, similar to another earlier
study [14], this study provides clear evidence of the
major interruption to the classical epidemiological tran-
sition brought about by the HIV/AIDS epidemic. Sec-
ond, while this study’s goal was to characterize mortality
patterns over time and empirically assess the changing
relations between overall mortality levels and cause
compositions, focusing on population-level patterns may
mask heterogeneity in these patterns by social, economic
and other indicators. Future analyses exploring hetero-
geneity in transition trajectories by social groups may
identify important differentials and disparities as well as
potential explanations of underlying patterns and drivers
of epidemiological change.
Evidence suggests that the Agincourt population is
undergoing dynamic socioeconomic change [34] while
concurrently experiencing high prevalence of HIV [53]
and risk factors for cardiometabolic diseases, particularly
hypertension [54]. Our findings imply that the epidemio-
logical transition will continue to be protracted in the
near future, especially in the middle adult age categories.
As more people living with HIV/AIDS access antiretro-
viral treatment, concentration of mortality will shift to-
wards older age categories and the contribution of
cardiovascular and other chronic non-communicable
diseases will become more apparent. Further, while base-
line data suggests little interaction of ART and cardio-
metabolic disease risk [54], greater ART uptake and
resulting prolonged survival highlights the need for fur-
ther studies on the interaction of HIV, cardiometabolic
disease and ageing. Hence, our results suggest a need to
realign the health care system to cater concurrently for
multiple disease conditions.
Conclusion
This study has provided a detailed examination of the
changing epidemiological profile of a rural South African
population prior to and throughout the emergence of
the HIV/AIDS epidemic in the absence of treatment,
and the resulting changes in the context of PMTCT and
ART rollout. Grounded in a robust statistical framework
permitting detailed empirical assessment relating mor-
tality levels to cause of death composition, our findings
suggest that the Agincourt population is experiencing a
protracted transition, with multiple stages overlapping
and changes incomplete. This calls for continuous moni-
toring of the trajectory of the transition in order to ad-
vise policy makers around health planning and resource
allocation and highlights the value of HDSS. Increas-
ingly, the intersection and interaction of HIV and
ART, non-communicable disease risk factors such as
rising hypertension, obesity and type-2 diabetes and
complex social, economic and behavioral changes oc-
curring in the population (for example, rising labour
migration in young women [55]) will impact contin-
ued progress in reducing premature mortality and im-
proving health. This study highlights the need for
integrated healthcare planning and program delivery
to improve access and adherence to treatment for
Kabudula et al. BMC Public Health  (2017) 17:424 Page 13 of 15
HIV and non-communicable diseases. Finally, our
findings from a local, rural setting over an extended
period contribute to the evidence base to inform fur-
ther refinement and advancement of health and epi-
demiological transition theory.
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